New cancer clinical trial: Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

Published on: June 27, 2018 at 12:00PM
Conditions:   HER2-positive Breast Cancer;   Operable Breast Cancer
Interventions:   Drug: Trastuzumab + Paclitaxel;   Drug: Pegfilgrastim
Sponsors:   Centre Leon Berard;   Amgen
Not yet recruiting
https://ift.tt/2ICck3D